Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Anesthesia Management in Redo Mitral Valve Replacement Surgery in a Patient With a Rare Blood Group: A Case Report Publisher



Azarfarin R1 ; Ziyaeifard M1 ; Alizadehasl A1 ; Roudini K2 ; Hadipourzadeh F3 ; Jamalian J3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cardio-Oncology Research Center, Rajaie Cardiovascular Research Center, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Internal Medicine, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Rajaie Cardiovascular Research Center, Iran University of Medical Sciences, Tehran, Iran

Source: Anesthesiology and Pain Medicine Published:2022


Abstract

Introduction: One of the conditions leading to hemolysis in patients with artificial metallic heart valves is valvular dysfunction. In case of symptomatic hemolysis, a blood transfusion may be needed along with standard treatments. Inattention to the differential diagnosis of hemolysis and making decisions based on causes that are more obvious can lead to incorrect approaches. Case Presentation: In this case report, we presented a case with a previously undiagnosed rare blood group (positive antibody anti-E, anti-c, anti-Kell), undergoing reoperation of mitral valve replacement (MVR), who developed severe hemolysis and subsequent acute renal failure secondary to incompatible blood transfusion and required hemodialysis. Conclusions: In this patient, hemolysis was solely attributed to mitral valve dysfunction. By timely diagnosis of the subtype of her blood group and appropriate decision-making during surgery, adverse blood transfusion outcomes were prevented. © 2022 Author(s).